Insider Trading Alert - CNBKA, AMRC And CHE Traded By Insiders
Yesterday, Nov. 9, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,037.40 to $6,950,097.00.
Highlighted Stocks Traded by Insiders:
Century Bancorp (CNBKA) - FREE Research Report
Filler James J, who is 10% Owner at Century Bancorp, bought 500 shares at $44.25 on Nov. 9, 2015. Following this transaction, the 10% Owner owned 474,810 shares meaning that the stake was boosted by 0.11% with the 500-share transaction.
The shares most recently traded at $44.30, up $0.05, or 0.11% since the insider transaction. Historical insider transactions for Century Bancorp go as follows:
- 4-Week # shares bought: 6,743
- 12-Week # shares bought: 35,748
- 24-Week # shares bought: 501,090
The average volume for Century Bancorp has been 3,900 shares per day over the past 30 days. Century Bancorp has a market cap of $162.2 million and is part of the financial sector and banking industry. Shares are up 12.43% year-to-date as of the close of trading on Monday.
Century Bancorp, Inc. operates as a bank holding company for Century Bank and Trust Company that provides banking products and services in Massachusetts. The stock currently has a dividend yield of 1.07%. The company has a P/E ratio of 11.1.
Exclusive Offer: Get the latest Stock Analysis on CNBKA - FREE
rates Century Bancorp as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full
Century Bancorp Ratings Report
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Ameresco (AMRC) - FREE Research Report
Gagnon Neil, who is 10% Owner at Ameresco, bought 22,129 shares at $6.83 on Nov. 9, 2015. Following this transaction, the 10% Owner owned 1.8 million shares meaning that the stake was boosted by 1.24% with the 22,129-share transaction.
The shares most recently traded at $6.62, down $0.21, or 3.17% since the insider transaction. Historical insider transactions for Ameresco go as follows:
- 4-Week # shares bought: 18,377
- 4-Week # shares sold: 3,680
- 12-Week # shares bought: 187,297
- 12-Week # shares sold: 3,680
- 24-Week # shares bought: 269,212
- 24-Week # shares sold: 3,680
The average volume for Ameresco has been 62,800 shares per day over the past 30 days. Ameresco has a market cap of $196.8 million and is part of the services sector and diversified services industry. Shares are down 4.71% year-to-date as of the close of trading on Monday.
Ameresco, Inc. provides comprehensive services, energy efficiency, infrastructure upgrades, asset sustainability, and renewable energy solutions for businesses and organizations in North America and Europe. The company operates through U.S. Regions, U.S. The company has a P/E ratio of 31.4. Currently, there is 1 analyst who rates Ameresco a buy, no analysts rate it a sell, and none rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on AMRC - FREE
rates Ameresco as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, weak operating cash flow and poor profit margins. Get the full
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Chemed (CHE) - FREE Research Report
Mcnamara Kevin J, who is president and CEO at Chemed, sold 6,000 shares at $157.02 on Nov. 9, 2015. Following this transaction, the president and CEO owned 167,736 shares meaning that the stake was reduced by 3.45% with the 6,000-share transaction.
The shares most recently traded at $152.99, down $4.03, or 2.63% since the insider transaction. Historical insider transactions for Chemed go as follows:
- 4-Week # shares sold: 1,493
- 12-Week # shares sold: 11,943
- 24-Week # shares sold: 33,962
The average volume for Chemed has been 171,600 shares per day over the past 30 days. Chemed has a market cap of $2.7 billion and is part of the health care sector and health services industry. Shares are up 44.27% year-to-date as of the close of trading on Monday.
Chemed Corporation provides hospice and palliative care services in the United States. It operates in two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The stock currently has a dividend yield of 0.61%. The company has a P/E ratio of 25.1. Currently, there is 1 analyst who rates Chemed a buy, no analysts rate it a sell, and 1 rates it a hold.
Exclusive Offer: Get the latest Stock Analysis on CHE - FREE
rates Chemed as a
. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.